News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
When to stop ICIs in dMMR/MSI-H metastatic colorectal cancer
Nov 2, 2024, 12:52

When to stop ICIs in dMMR/MSI-H metastatic colorectal cancer

Thor Halfdanarson, Medical Oncologist and Educator and Professor of Oncology at Mayo Clinic, shared an recent article by Ofer Margalit on X:

“When to stop ICIs in dMMR/MSI-H metastatic colorectal cancer…? It seems like 2 years is fine and even 1 year if complete response.

I am curious to know what others are doing, especially in the setting of complete response.”

Duration of immunotherapy in dMMR/MSI-H metastatic colorectal cancer patients.

Authors: Ofer Margalit, et al.

When to stop ICIs in dMMR/MSI-H metastatic colorectal cancer

 

cancer colorectal cancer ICIs immunotherapy Mayo Clinic MedOnc Ofer Margalit OncoDaily Oncology RadOnc Thor Halfdanarson
Special Coverage
Voices
Aug 24, 2025, 03:00
Giuseppe Minniti: Gliofocus Phase 3 Trial Explores PARP Inhibitors with Radiotherapy in GBM
Voices
Aug 24, 2025, 01:32
Minhua Chu: Zelgen Biopharma’s ZGGS34 Gets FDA Approval for Solid Tumor Study
Insight
Aug 24, 2025, 01:13
Discovering Approaches to Enhance CAR-NK Cell Antitumor Activity with CRISPR - MD Anderson Cancer Center
Voices
Aug 23, 2025, 23:27
Lauren Kriger Groner: Filming the Cracking Cancer Podcast with The White Ribbon Project
Voices
Aug 23, 2025, 22:57
Paolo Tarantino: Exploring IO and ADC Combinations at SITC25
Drugs
Aug 23, 2025, 22:35
LOCKTAC Molecular Glues Are Changing the Rules of Drug Discovery - Amgen
Voices
Aug 23, 2025, 22:10
Neeraj Agarwal: USPCCC 2025 with Alan H Bryce's Introductory Remarks
Voices
Aug 23, 2025, 21:58
Al-Ola A Abdallah: Reducing Platelet Transfusion Threshold Before LP in Hematologic Malignancy Patients
Voices
Aug 23, 2025, 21:42
Nina Niu Sanford: NRG-GI011 Has Enrolled and Randomized Its 1st Patient
Voices
Aug 23, 2025, 21:31
Rahul Banerjee Shared NEJM Study on Targeted Therapy of CAR+ T-Cell Lymphoma
Societies
Aug 23, 2025, 20:55
Advancing Cancer Treatment with Therapeutic Vaccines - MSKCC
Voices
Aug 23, 2025, 20:22
Joe Taylor's Last Week in the Lab at Fred Hutch Cancer Center - Hsieh Lab